DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. Funding Opportunities
  3. Synopsis of Open Program Funding Opportunities

Funding Opportunities

Synopsis of Open Program Funding Opportunities



FY21 Autism Research Program (ARP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award Program Announcement
Application Instructions 		March 19, 2021
  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $1,800,000 in direct costs (plus indirect costs).

Early-Career Investigator Partnering PI Option:

  • The maximum period of performance is 4 years.
  • The maximum allowable funding for the entire period of performance is $2,100,000 for direct costs (plus indirect costs).
 Pre-Application:
May 3, 2021

Invitation to Submit an Application:
June 2021

Application:
August 5, 2021
Idea Development Award Program Announcement
Application Instructions 		March 19, 2021
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $550,000 in direct costs (plus indirect costs).
  • For multiple PIs, the combined funding for all PIs for the entire period of performance may not exceed $550,000 in direct costs (plus indirect costs).
 Pre-Application:
May 3, 2021

Invitation to Submit an Application:
June 2021

Application:
August 5, 2021
Clinical Translational Research Award Program Announcement
Application Instructions 		March 19, 2021
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $600,000 in direct costs (plus indirect costs).
 Pre-Application:
May 3, 2021

Invitation to Submit an Application:
June 2021

Application:
August 5, 2021
Career Development Award Program Announcement
Application Instructions 		March 19, 2021
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $500,000 in direct costs (plus indirect costs).
 Pre-Application:
May 3, 2021

Invitation to Submit an Application:
June 2021

Application:
August 5, 2021







ERP

FY21 Epilepsy Research Program (ERP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award Program Announcement
Application Instructions 		April 13, 2021 Level I:
  • Maximum funding of $300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
  • Indirect costs may be proposed in accordance with the institution’s rate agreement.
Level II:
  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
  • Indirect costs may be proposed in accordance with the institution’s rate agreement.
 Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021
Quality of Life Award Program Announcement
Application Instructions 		April 13, 2021 Level I:
  • Maximum funding of $300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
  • Indirect costs may be proposed in accordance with the institution’s rate agreement.
Level II:
  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
  • Indirect costs may be proposed in accordance with the institution’s rate agreement.
 Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021
Research Partnership Award Program Announcement
Application Instructions 		April 13, 2021 Level I:
  • Maximum funding of $1,300,000 in total costs.
  • Maximum period of performance is 3 years.
  • Indirect costs may be proposed in accordance with the institution's rate agreement.
Level II:
  • Maximum funding of $3,100,000 in total costs.
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution's rate agreement.
 Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021

GWIRP

FY21 Gulf War Illness Research Program (GWIRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Award Program Announcement
Application Instructions 		March 11, 2021 Maximum funding of $200,000 for direct costs (plus indirect costs).

Maximum funding of $220,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum period of performance is 2 years.

 Pre-Application (Preproposal): May 7, 2021

Application: August 19, 2021
Research Advancement Award Program Announcement
Application Instructions 		March 11, 2021 Maximum funding of $600,000 for direct costs (plus indirect costs).

Maximum funding of $620,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum period of performance is 3 years

 Pre-Application (Preproposal): May 7, 2021

Application: August 19, 2021
Clinical Evaluation Award Program Announcement
Application Instructions 		March 11, 2021 Maximum funding of $1,500,000 for direct costs (plus indirect costs).

Maximum funding of $1,520,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum funding of $1,700,000 for direct costs with the Clinical Consortium Collaboration Option (plus indirect costs).

Maximum period of performance is 3 years

 Pre-Application (Preproposal): May 7, 2021

Application: August 19, 2021
Therapeutic/Biomarker Trial Award Program Announcement
Application Instructions 		March 11, 2021 Maximum funding of $5,000,000 for direct costs (plus indirect costs).

Maximum funding of $5,020,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum funding of $5,500,000 for direct costs with the Clinical Consortium Collaboration Option (plus indirect costs).

Maximum period of performance is 3 years

 Pre-Application (Preproposal): May 7, 2021

Application: August 19, 2021
New Investigator Award Program Announcement
Application Instructions 		March 11, 2021 Maximum funding of $500,000 for direct costs (plus indirect costs).

Maximum funding of $520,000 for direct costs with the Biorepository Contribution Option (plus indirect costs).

Maximum period of performance is 3 years.

 Pre-Application (Preproposal): May 7, 2021

Application: August 19, 2021

FY21 Lung Cancer Research Program (LCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Translational Research Partnership Award Program Announcement
Application Instructions
 March 1, 2021
  • Maximum combined funding of $1,200,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Letter of Intent):
July 14, 2021

Letter of Intent is required.

Application: July 28, 2021
Investigator Initiated Translational Research Award Program Announcement
Application Instructions
 March 1, 2021
  • Maximum funding of $600,000 in direct costs (plus indirect costs).
  • Period of performance should not exceed 3 years.
 Pre-Application (Preproposal): May 5, 2021

Preproposal is required; application submission is by invitation only.

Application: July 28, 2021
Idea Development Award Program Announcement
Application Instructions
 March 8, 2021
  • Maximum funding of $350,000 in direct costs (plus indirect costs).
  • Period of performance not to exceed 2 years.
 Pre-Application (Preproposal): May 5, 2021

Preproposal is required; application submission is by invitation only.

Application: July 28, 2021


FY21 Orthotics and Prosthetics Outcomes Research Program (OPORP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Research Award (CRA) Program Announcement
Application Instructions
 April 1, 2021

The FY21 OPORP CRA offers two funding levels:

Funding Level 1:

  • Maximum funding of $350,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 2 years.

Funding Level 2:

  • Maximum funding of $2,000,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
July 15, 2021

Application:
July 29, 2021
Clinical Trial Award (CTA) Program Announcement
Application Instructions
 April 1, 2021

The FY21 OPORP CTA offers two funding levels:

Funding Level 1:

  • Maximum funding of $350,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 3 years.

Funding Level 2:

  • Maximum funding of $4,000,000 for total costs (direct costs plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
July 15, 2021

Application:
July 29, 2021

FY21 Ovarian Cancer Research Program (OCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Omics Consortium Award Program Announcement
Application Instructions 		March 25, 2021 Omics Development Award Option:
  • Maximum funding of $400,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.

Omics Consortium Award Option:

  • Maximum funding of $2.5 million for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application:
June 24, 2021

Application:
July 8, 2021


FY21 Peer Reviewed Alzheimer's Research Program (PRARP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Convergence Science Research Award Program Announcement
Application Instructions
 April 8, 2021 Level I:
  • Maximum funding of $225,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.

Level II:

  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.

For Both Levels:

Indirect costs may be proposed in accordance with the institution’s rate agreement. 		Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021
Innovation in Care and Support Award Program Announcement
Application Instructions
 April 8, 2021 Level I:
  • Maximum funding of $225,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.

Level II:

  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.

For Both Levels:

Indirect costs may be proposed in accordance with the institution’s rate agreement. 		Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021
Research Partnership Award Program Announcement
Application Instructions
 April 8, 2021
  • Funding limit is $1.3 million (M) in total costs.
  • Maximum period of performance is 3 years.
Indirect costs may be proposed in accordance with the institution’s rate agreement. 		Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021
Accelerating Diagnostic Research Award Program Announcement
Application Instructions
 April 8, 2021
  • Funding limit is $2.8M in total costs.
  • Maximum period of performance is 4 years.
Indirect costs may be proposed in accordance with the institution’s rate agreement. 		Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021
Leveraging Approaches for Innovation in Care and Support Award Program Announcement
Application Instructions
 April 8, 2021
  • Funding limit is $2.8M in total costs.
  • Maximum period of performance is 4 years.
Indirect costs may be proposed in accordance with the institution’s rate agreement. 		Pre-Application (Letter of Intent):
June 14, 2021

Application:
July 21, 2021

FY21 Peer Reviewed Cancer Research Program (PRCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Behavioral Health Science Award Program Announcement
Application Instructions 		March 24, 2021
  • The maximum allowable funding for the entire period of performance is $1,000,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
July 29, 2021

Application: August 18, 2021
Career Development Award - Fellow Option Program Announcement
Application Instructions 		March 24, 2021
  • The maximum allowable funding for the entire period of performance is $400,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Letter of Intent):
July 29, 2021

Application: August 18, 2021
Idea Award Program Announcement
Application Instructions 		March 24, 2021
  • The maximum allowable funding for the entire period of performance is $500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal):
May 20, 2021

Application:
September 8, 2021
Impact Award Program Announcement
Application Instructions 		March 24, 2021
  • The maximum allowable funding for the entire period of performance is $1,250,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal):
May 20, 2021

Application:
September 8, 2021
Translational Team Science Award Program Announcement
Application Instructions 		March 24, 2021
  • The maximum allowable funding for the entire period of performance is $2,500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
July 29, 2021

Application: August 18, 2021

FY21 Peer Reviewed Medical Research Program (PRMRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award Program Announcement
Application Instructions 		March 15, 2021 Clinical Trial:
  • Funding limit not defined; requested funding must be appropriate for the scope of work proposed.
  • Maximum period of performance is 4 years for the clinical trial.
Planning Phase with Clinical Trial Option:
  • Maximum of $500,000 for direct costs (plus indirect costs) for the Planning Phase Option.
  • Maximum period of performance is 18 months.
 Pre-Application (Preproposal): May 13, 2021

Application: August 26, 2021
Discovery Award Program Announcement
Application Instructions 		March 15, 2021
  • Maximum funding of $200,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
 Pre-Application (Letter of Intent): April 29, 2021

Application: May 13, 2021
Focused Program Award Program Announcement
Application Instructions 		March 15, 2021
  • Maximum funding of $7.2 million for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Preproposal): May 13, 2021

Application: August 26, 2021
Investigator-Initiated Research Award Program Announcement
Application Instructions 		March 15, 2021
  • Maximum of $1.6 million for direct costs (plus indirect costs).
  • Maximum of $2.0 million for direct costs (plus indirect costs) for applications including a Partnering PI Option.
  • Maximum period of performance is 4 years.
 Pre-Application (Preproposal): April 28, 2021

Application: September 2, 2021
Technology/Therapeutic Development Award Program Announcement
Application Instructions 		March 15, 2021 Funding Level 1:
  • Maximum funding of $2 million for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
Funding Level 2:
  • Maximum funding of $4 million for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Preproposal): April 28, 2021

Application: September 2, 2021



FY21 Peer Reviewed Orthopaedic Research Program (PRORP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Applied Research Award (ARA) Program Announcement
Application Instructions 		April 1, 2021
  • The maximum allowable funding for the entire period of performance is $725,000 for total costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal):
May 27, 2021

Application:
September 10, 2021
Clinical Trial Award (CTA) Program Announcement
Application Instructions 		April 1, 2021 Research Level 1:
  • The maximum allowable funding for the entire period of performance is $2.25 million (M) for total costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4

Research Level 2:

  • The maximum allowable funding for the entire period of performance is $2.75M for total costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal):
May 27, 2021

Application:
September 10, 2021
Clinical Translational Research Award (CTRA) Program Announcement
Application Instructions 		April 1, 2021
  • The maximum allowable funding for the entire period of performance is $1.5M for total costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal):
May 27, 2021

Application:
September 10, 2021


FY21 Prostate Cancer Research Program (PCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Early Investigator Research Award Program Announcement
Application Instructions 		April 5, 2021
  • The maximum allowable funding for the entire period of performance is $300,000 for direct costs.
  • The maximum period of performance is 2 years.
 Pre-application (Letter of Intent): June 17, 2021

Confidential Letters of Recommendation: July 7, 2021

Application: July 1, 2021
Physician Research Award Program Announcement
Application Instructions 		April 5, 2021
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • The maximum period of performance is 4 years.
 Pre-application (Letter of Intent): June 17, 2021

Confidential Letters of Recommendation: July 7, 2021

Application: July 1, 2021
Translational Science Award Program Announcement
Application Instructions 		April 5, 2021
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • The maximum period of performance is 3 years.
 Pre-application (Letter of Intent): July 15, 2021

Application: July 29, 2021
Health Disparity Research Award Program Announcement
Application Instructions 		April 5, 2021
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • The maximum period of performance is 3 years.
 Pre-application (Letter of Intent): July 15, 2021

Application: July 29, 2021
Idea Development Award Program Announcement
Application Instructions 		April 5, 2021
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • The maximum period of performance is 3 years.
 Pre-application (Letter of Intent): September 2, 2021

Application: September 23, 2021
Clinical Consortium Award Program Announcement
Application Instructions 		April 8, 2021 Coordinating Center:
  • Maximum funding of $7,200,000 for direct costs (plus indirect costs), including no less than $500,000 per year for support of two or more Affiliate Clinical Research Sites.
  • Maximum period of performance is 4 years.

Clinical Sites:

  • Maximum funding of $1,200,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years
 Pre-Application (Letter of Intent): September 2, 2021

Application: September 23, 2021
Data Science Award Program Announcement
Application Instructions 		April 8, 2021
  • Maximum funding of $1,000,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.
 Pre-Application (Letter of Intent): July 15, 2021

Application: July 29, 2021
Health Equity Research and Outcomes Improvement Consortium (HEROIC) Award Program Announcement
Application Instructions 		April 8, 2021 Phase 1:
  • Maximum funding of $2,700,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.

Phase 2:

  • Maximum funding of $10,000,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
 Pre-Application (Letter of Intent): July 15, 2021

Application: July 29, 2021


FY21 Spinal Cord Injury Research Program (SCIRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Clinical Trial Award Program Announcement
Application Instructions 		March 29, 2021
  • The maximum allowable funding for the entire period of performance is $3 million (M) for direct costs.
  • The maximum period of performance is 4 years.
 Pre-Application (Preproposal): May 24, 2021

Application:
September 3, 2021
Translational Research Award Program Announcement
Application Instructions 		March 29, 2021
  • The maximum allowable funding for the entire period of performance is $1.25M for direct costs.
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal): May 24, 2021

Application:
September 3, 2021
Investigator-Initiated Research Award Program Announcement
Application Instructions 		March 29, 2021
  • The maximum allowable funding for the entire period of performance is $500,000 for direct costs.
  • The maximum period of performance is 3 years.
 Pre-Application (Preproposal): May 24, 2021

Application:
September 3, 2021


FY21 Tick-Borne Disease Research Program (TBDRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Career Development Award Program Announcement
Application Instructions
March 22, 2021
  • Maximum funding of $300K for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal): May 26, 2021

Preproposal is required; application submission is by invitation only.

Application: August 27, 2021
Idea Development Award Program Announcement
Application Instructions
March 22, 2021
  • Maximum funding of $600K for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application (Preproposal): May 26, 2021

Preproposal is required; application submission is by invitation only.

Application: August 27, 2021


FY21 Tuberous Sclerosis Complex Research Program (TSCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Exploration - Hypothesis Development Award Program Announcement
Application Instructions 		April 1, 2021
  • The maximum period of performance is 2 years.
  • The maximum allowable funding for the entire period of performance is $150,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent): June 17, 2021

Application: July 8, 2021
Idea Development Award Program Announcement
Application Instructions 		April 1, 2021
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $500,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
 Pre-Application (Letter of Intent): June 17, 2021

Application: July 8, 2021
Clinical Translational Research Award Program Announcement
Application Instructions 		April 1, 2021
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $750,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution's negotiated rate agreement.
 Pre-Application (Letter of Intent): June 17, 2021

Application: July 8, 2021

Last updated Wednesday, April 14, 2021